Skip to content
Home/Companies/MedTech/Acufocus, Inc.

Acufocus, Inc.

MedTech·USA·Exited 2023
Entry
–
Hold
–
Exit
2023

Who owns Acufocus, Inc.?

Acufocus, Inc. is an American MedTech company, now owned by Bausch + Lomb, which acquired it in 2023 from The Carlyle Group.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
The Carlyle Group
Investor
The Carlyle Group
Carlyle healthcare fund · 2001 · Buyout

Key facts

HQUSA
SectorMedTech
Exit Type
Trade Sale
Buyer
Bausch + Lomb
Exit Year
2023

More from Carlyle healthcare fund

Other portfolio companies in the same fund.

Edscha
Active
MobilityGermany· 2002

More The Carlyle Group portfolio companies

From the same investor, across funds.

1E
1E
Exited 2025
SaaSUK
to TeamViewer
A Twosome Place
Active
HospitalityUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
PharmaUS
Abbisko Healthcare
Active
BiotechChina
Abrigo
Abrigo
Active
SaaSUS
Accelerate Learning
Accelerate Learning
Active
SaaSUS

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Appasamy
Appasamy
Active
Warburg PincusIndia
Argá Medtech SA
Argá Medtech SA
Active
Enterprise IrelandSwitzerland

Questions

Who owns Acufocus, Inc.?

Acufocus, Inc. is now owned by Bausch + Lomb, which acquired it in 2023 from The Carlyle Group.

When did Bausch + Lomb acquire Acufocus, Inc.?

Bausch + Lomb acquired Acufocus, Inc. in 2023, buying from The Carlyle Group.

Who did Acufocus, Inc. sell to?

The Carlyle Group sold Acufocus, Inc. to Bausch + Lomb in 2023 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue